Formely MobiMedQR, The Dash Alliance is proud to launch My Rare ID, a digital platform that hosts your critical medical details and provides 24/7 accessiblity in emergent medical situations. We seek to prevent misdiagnosis, reduce time to treatment and promote better outcomes through precision emergency care and instant disease education from respected medical sources.
Launching in Fall 2022, Cumulus is a 100% virtual cloud-based hospital focused on expediting diagnoses and access to treatments for patients across the globe. Learn how you can join this unique community today.
Since 2016, our team has worked to provide bespoke solutions to industry stakeholders. From advisory board planning and hosting to cultivating meaningful and actionable data from qualitative patient data, the Dash Connect team is committed to amplifying the patient voice with an array of impactful services and tools.
We know how important it is to keep patient and research communities connected. That's why we work with non-profit organizations and industry stakeholders globally to host affordable ground, virtual, and hybrid events.
From research meetings to product launches, we leverage our expertise to help host impactful virtual events.
Learn more about what we do here.
Interested in hosting a virtual event for your community? Contact us at hello@thedashalliance.com.
Launched in 2018, The Rare Fair was the first-ever virtual event for the global rare disease community.
Coming in March 2023, we'll launch an expanded Rare Fair agenda, with two days of educational content on March 29-30.
On April 1st, we'll launch the first-ever virtual event for kids and parents, "The Rare Fair: Junior Edition".
Join us on April 1st for the 2nd Annual hybrid rare disease event for kids and their families!
Register now at www.therarefair.com
We know the key to sourcing solutions in the rare disease community is collaboration. Rare72 is a virtual hackathon-style model designed to tackled to unite the international rare disease community while addressing common challenges in rare disease.
Learn more at Rare72.